INST IMMUNOLOGII I TERAPII DOŚWIADCZALNEJ PAN has a total of 12 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Poland and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SHANGHAI CELL THERAPY GROUP CO LTD, GUANGZHOU BIO GENE TECH CO LTD and ZHEJIANG COMPVSS BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Poland | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Gamian Andrzej | 6 |
#2 | Rybka Jacek | 4 |
#3 | Boratyński Janusz | 3 |
#4 | Gotszalk Teodor | 2 |
#5 | Mielczarski Jerzy | 2 |
#6 | Korzeniowska-Kowal Agnieszka | 2 |
#7 | Dąbrowska Krystyna | 2 |
#8 | Lipiński Tomasz | 2 |
#9 | Górski Andrzej | 2 |
#10 | Wietrzyk Joanna | 2 |
Publication | Filing date | Title |
---|---|---|
PL411685A1 | Conjugat and its application | |
PL411372A1 | Bacteriophages suitable for production of vaccines and method for obtaining them | |
PL400065A1 | Minimal medium for cultivation of bacteria, in particular to multiply bacteriophages | |
PL394703A1 | Method and kit detection of enzootic bovine leukosis | |
PL392774A1 | Competitive method for obtaining bacteriophage formulations | |
PL386351A1 | Method of manufacturing the drug carrier polyanion conjugates | |
PL386174A1 | Method of bonding bacterial lipopolysaccharides into the solid phase | |
PL382460A1 | Method for endotoxin isolation from bacterial mass | |
PL381730A1 | Purified bacteriophage preparation, the manner of obtaining it and application | |
PL381607A1 | Resonance sensor | |
PL381606A1 | The manner of detection of the tested substance |